1. Home
  2. NMRA vs CVEO Comparison

NMRA vs CVEO Comparison

Compare NMRA & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • CVEO
  • Stock Information
  • Founded
  • NMRA 2019
  • CVEO 1977
  • Country
  • NMRA United States
  • CVEO United States
  • Employees
  • NMRA N/A
  • CVEO N/A
  • Industry
  • NMRA
  • CVEO Hotels/Resorts
  • Sector
  • NMRA
  • CVEO Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • CVEO Nasdaq
  • Market Cap
  • NMRA 268.5M
  • CVEO 284.2M
  • IPO Year
  • NMRA 2023
  • CVEO N/A
  • Fundamental
  • Price
  • NMRA $1.94
  • CVEO $21.42
  • Analyst Decision
  • NMRA Hold
  • CVEO Strong Buy
  • Analyst Count
  • NMRA 8
  • CVEO 1
  • Target Price
  • NMRA $5.83
  • CVEO $27.00
  • AVG Volume (30 Days)
  • NMRA 506.9K
  • CVEO 64.3K
  • Earning Date
  • NMRA 11-11-2025
  • CVEO 10-29-2025
  • Dividend Yield
  • NMRA N/A
  • CVEO 2.35%
  • EPS Growth
  • NMRA N/A
  • CVEO N/A
  • EPS
  • NMRA N/A
  • CVEO N/A
  • Revenue
  • NMRA N/A
  • CVEO $634,027,000.00
  • Revenue This Year
  • NMRA N/A
  • CVEO N/A
  • Revenue Next Year
  • NMRA N/A
  • CVEO $3.13
  • P/E Ratio
  • NMRA N/A
  • CVEO N/A
  • Revenue Growth
  • NMRA N/A
  • CVEO N/A
  • 52 Week Low
  • NMRA $0.61
  • CVEO $18.01
  • 52 Week High
  • NMRA $17.19
  • CVEO $28.23
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 58.78
  • CVEO N/A
  • Support Level
  • NMRA $1.70
  • CVEO N/A
  • Resistance Level
  • NMRA $1.93
  • CVEO N/A
  • Average True Range (ATR)
  • NMRA 0.13
  • CVEO 0.00
  • MACD
  • NMRA 0.01
  • CVEO 0.00
  • Stochastic Oscillator
  • NMRA 82.05
  • CVEO 0.00

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

Share on Social Networks: